Neurocrine Biosciences
NBIXNeurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbena …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Neurocrine Biosciences
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/3/2025 | Sell | Lyons, Gary A. | Director | $152.6 | $2,289,083 |
| 11/28/2025 | Sell | Benevich, Eric | Chief Commercial Officer | $151.7 | $905,881 |
| 11/25/2025 | Sell | Morrow, George J. | Director | $143.4 | $2,150,513 |
| 11/5/2025 | Sell | Rastetter, William H. | Director | $151.8 | $2,732,690 |
| 11/4/2025 | Sell | Gano, Kyle | Chief Executive Officer | $142.0 | $42,591 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)